Nestor O. Concha
Research Subjects
Nestor O. Concha has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Alan Price
GSK, 1250 South Collegeville Road, Collegeville, PA 19426, USA
1 shared publication - Apirat Chaikuad
GSK, Gunnels Wood Road, Stevenage, Hertfordshire
1 shared publication - Charlotte K. Stanborough
GSK, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK
1 shared publication - Christoph W. Müller
Molecular Systems Biology Unit, European Molecular Biology Laboratory (EMBL), Meyerhofstrasse 1, 69117 Heidelberg, Germany
1 shared publication - Chun-Wa Chung
Structural and Biophysical Sciences, GlaxoSmithKline R&D, Stevenage SG1 2NY, United Kingdom
1 shared publication - Daniel J. Norman
GSK, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK
1 shared publication
Latest Publications
- Open Access
- 5 March 2025
- Published by American Chemical Society (ACS) in ChemRxiv
‘Direct-to-biology’ drives optimisation of a cell-active covalent inhibitor of WRN helicase
We report a ‘direct-to-biology’ (D2B) approach for optimising covalent acrylamide binders of protein targets and apply this to the identification of a selective and cell-active inhibitor of Werner (WRN) helicase. Inhibition of WRN helicase activity exhibits a synthetic lethal relationship with cancers displaying high microsatellite instability (MSI-H) and is being pursued as a therapeutic strategy in the clinic. Using intact-protein liquid chromatography-mass spectrometry (LC-MS) screening, we identified acrylamide fragment binders of the WRN helicase domain and then used covalent D2B chemistry to optimise these initial hits. Our efforts ultimately afforded a potent covalent inhibitor of WRN-mediated DNA unwinding, which displays selective, concentration-dependent cellular engagement of WRN, and demonstrates synthetic lethality in an MSI-H setting. Furthermore, our inhibitor targets a distinct conformation of WRN helicase compared to the current clinical covalent inhibitor, presenting a complementary approach for covalent inhibition of WRN helicase. This work demonstrates how D2B chemistry platforms can be used to explore structure-activity relationships in a modular fashion, while reducing investment of human and material resources.
- 5 March 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open Access‘Direct-to-biology’ drives optimisation of a cell-active covalent inhibitor of WRN helicase
We report a ‘direct-to-biology’ (D2B) approach for optimising covalent acrylamide binders of protein targets and apply this to the identification of a selective and cell-active inhibitor of Werner (WRN) helicase. Inhibition of WRN helicase activity exhibits a synthetic lethal relationship with cancers displaying high microsatellite instability (MSI-H) and is being pursued as a therapeutic strategy in the clinic. Using intact-protein liquid chromatography-mass spectrometry (LC-MS) screening, we identified acrylamide fragment binders of the WRN helicase domain and then used covalent D2B chemistry to optimise these initial hits. Our efforts ultimately afforded a potent covalent inhibitor of WRN-mediated DNA unwinding, which displays selective, concentration-dependent cellular engagement of WRN, and demonstrates synthetic lethality in an MSI-H setting. Furthermore, our inhibitor targets a distinct conformation of WRN helicase compared to the current clinical covalent inhibitor, presenting a complementary approach for covalent inhibition of WRN helicase. This work demonstrates how D2B chemistry platforms can be used to explore structure-activity relationships in a modular fashion, while reducing investment of human and material resources.
- Open Access
- 3 September 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (9) , e0307850
Structural insight into the DNMT1 reaction cycle by cryo-electron microscopy
DNMT1 is an essential DNA methyltransferase that catalyzes the transfer of methyl groups to CpG islands in DNA and generates a prominent epigenetic mark. The catalytic activity of DNMT1 relies on its conformational plasticity and ability to change conformation from an auto-inhibited to an activated state. Here, we present four cryo-EM reconstructions of apo DNMT1 and DNTM1: non-productive DNA, DNTM1: H3Ub2-peptide, DNTM1: productive DNA complexes. Our structures demonstrate the flexibility of DNMT1’s N-terminal regulatory domains during the transition from an apo ‘auto-inhibited’ to a DNA-bound ‘non-productive’ and finally a DNA-bound ‘productive’ state of DNMT1. Furthermore, we address the regulation of DNMT1’s methyltransferase activity by a DNMT1-selective small-molecule inhibitor and ubiquitinated histone H3. We observe that DNMT1 binds DNA in a ‘non-productive’ state despite the presence of the inhibitor and present the cryo-EM reconstruction of full-length DNMT1 in complex with a di-ubiquitinated H3 peptide analogue. Taken together, our results provide structural insights into the reaction cycle of DNMT1.
- 3 September 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (9) , e0307850
Open AccessStructural insight into the DNMT1 reaction cycle by cryo-electron microscopy
DNMT1 is an essential DNA methyltransferase that catalyzes the transfer of methyl groups to CpG islands in DNA and generates a prominent epigenetic mark. The catalytic activity of DNMT1 relies on its conformational plasticity and ability to change conformation from an auto-inhibited to an activated state. Here, we present four cryo-EM reconstructions of apo DNMT1 and DNTM1: non-productive DNA, DNTM1: H3Ub2-peptide, DNTM1: productive DNA complexes. Our structures demonstrate the flexibility of DNMT1’s N-terminal regulatory domains during the transition from an apo ‘auto-inhibited’ to a DNA-bound ‘non-productive’ and finally a DNA-bound ‘productive’ state of DNMT1. Furthermore, we address the regulation of DNMT1’s methyltransferase activity by a DNMT1-selective small-molecule inhibitor and ubiquitinated histone H3. We observe that DNMT1 binds DNA in a ‘non-productive’ state despite the presence of the inhibitor and present the cryo-EM reconstruction of full-length DNMT1 in complex with a di-ubiquitinated H3 peptide analogue. Taken together, our results provide structural insights into the reaction cycle of DNMT1.